A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study
Selle, F., Wittnebel, S., Biron, P., Gravis, G., Roubaud, G., Bui, B.N., Delva, R., Bay, J.O., Fléchon, A., Geoffrois, L., Caty, A., Soares, D.G., de Revel, T., Fizazi, K., Gligorov, J., Micléa, J.M., Dubot, C., Provent, S., Temby, I., Gaulet, M., Horn, E., Brindel, I., Lotz, J.P.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
The TAXIF II Protocol Final Results: A Phase II Trial of High-Dose Chemotherapy Supported by Haematopoietic Stem Cell Transplantation in Patients with Disseminated Germ-Cell Tumors Failing Chemotherapy and with Adverse Prognostic Factors
Selle, F., Fizazi, K., Biron, P., Gravis-Mescam, G., Bui, B., Bay, J., Flechon, A., Dubot, C., Caty, A., Burcoveanu, D., Delva, R., de Revel, T., Miclea, J.M., Gaulet, M., Horn, E., Provent, S., Temby, I., Brindel, I., Khalil, J., Gligorov, J., Lotz, J.-P.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study
Selle, F, Wittnebel, S, Biron, P, Gravis, G, Roubaud, G, Bui, B N, Delva, R, Bay, J O, Fléchon, A, Geoffrois, L, Caty, A, Soares, D G, de Revel, T, Fizazi, K, Gligorov, J, Micléa, J M, Dubot, C, Provent, S, Temby, I, Gaulet, M, Horn, E, Brindel, I, Lotz, J P
Published in Annals of oncology (01.09.2014)
Get full text
Published in Annals of oncology (01.09.2014)
Journal Article